Kuliah Shock Cardiogenic

Embed Size (px)

Citation preview

  • 7/26/2019 Kuliah Shock Cardiogenic

    1/42

    SHOCK CARDIOGENIC

    Bag. Anestesiologi dan Therapy Intensive Care

    Fakultas Kedokteran Universitas Islam Sumatera Utara

    20!

    Fir

  • 7/26/2019 Kuliah Shock Cardiogenic

    2/42

    DEFINISI

    IT IS NOTLOW BLOODPRESSURE!!!

    IT ISHYPOPERFUSION..

    Gangguan dari perfusi jaringan yangterjadi akibat adanya

    ketidakseimbangan antara suplaioksigen ke sel dengan kebutuhan

    oksigen dari sel tersebut.

    Semua jenis shock mengakibatkan

    gangguan pada perfusi jaringan yangselanjutnya berkembang menjadigagal sirkulasi akut atau disebut juga

    sindroma shock

  • 7/26/2019 Kuliah Shock Cardiogenic

    3/42

    Shock adalah kondisi saat tansot o$DO%& d#li'#( O%) k# *ain"an "a"al +#+

    k#-,t,han +#ta-olik di *ain"an t#s#-,

  • 7/26/2019 Kuliah Shock Cardiogenic

    4/42

    Always a symptom of primary caus

    Inad!uat "lood #ow to mt tissu o$y%n dm

    &ay " associatd wit' 'ypotnsion

    Associatd wit' si%ns of 'ypoprfusion( mntal stc'an%, oli%uria, acidosis

    S'oc)

  • 7/26/2019 Kuliah Shock Cardiogenic

    5/42

    *+-+*

    Type of shock

    Hypovolemic

    Cardiogenic

    Distributive [vasomotordysfunction]

    . High or normalresistance

    . Low resistance

    Obstructive

    Primary mechanism

    Volume loss

    ump failure

    !"panded venous capacitance[pooling]# CO normal or low

    $rteriovenous shuntingCO normal or high!"tracardiac obstruction ofmain channel of blood flow

    Clinical causes

    !"ogenous %lood loss due to hemorrhage lasma loss due to burn# inflammation &luid and electrolyte loss due to vomit ing# dehydration# osmolal diuresis [diabetes]

    !ndogenous !"travasation due to inflammation# trauma

    sna'e venom# pheochromocytoma

    (yocardial infarctionHeart failure

    $rrhythmia)ntracardiac obstruction

    Hypodynamic septic shoc' due to gram*neg+pinal shoc'# ,arcotic over dose# barbitura

    neumonia# peritonitis# abscess# reactive h

    Vena caval obstruction# pericarditis [cardiacpulmonary embolism# aorta dissecting aneu

    Classification of shoc' states

    -eil# (H et al Card iovascular +ystem failu

    emergency medicine. +chwart/. 01 [ed] -%

  • 7/26/2019 Kuliah Shock Cardiogenic

    6/42

    *+-+*

    Hemorrhagic

    Sign & Symptoms

    allor# fainting+'in clammy# cold

    6achycardia

    Oliguria

    Collapse

    Laboratory

    Hct, Hb

    Cardiogenic

    Sign & Symptoms

    allor# fainting+'in clammy# cold

    $rrhythmias

    Oliguria

    Collapse

    Laboratory

    Cardiac en/ymes

    !C0

    Traumatic

    Sign & Symptoms

    History 7 hysicalevidence of in8ury

    Oliguria

    6achycardia

    Collapse

    Laboratory

    9*1ays# C6*scan

    PathophysiologyDirect in8ury to organ

    Therapy

    2. 1epair in8ury

    :. &luids

    ;. %lood

    Pathophysiology %lood volume

    Therapy

    2. &luids

    :. %lood

    ;. Control %leeding

    Pathophysiology Cardiac output

    Therapy

    2. $ntiarrhythmic

    :. Vasopressors

    ;. Vasodilators

    Septic

    Sign & Sympt

    &ever# chills+'in warm

    6achycardia

    Oliguria

    $ltered mental

    CollapseLaboratory

    [

  • 7/26/2019 Kuliah Shock Cardiogenic

    7/42

    *+-+*

    A./ production + lactic acidosis

    Sur0i0al + dlaydmor"idity + mortality

    Intr0ntion + sta"ili1ation

    Cllular functionimpaird

    Continud 0olum loss

    &m"ran porosity

    &o0mnt of#uid from

    intra0ascular tointrstitial

    spacs

    2yso1ymal

    la)a%

    Cllular autodi%st

    Irr0rsi"l s'oc)

    intr0ntion

    DEA.HNo3 intr0ntion

    Cllular 'ypo$ia +anaro"ic

    mta"olism

    /A.HO/H4SIO, CON.5N

  • 7/26/2019 Kuliah Shock Cardiogenic

    8/42

    *+-+*

    /RE62OAD CON.RAC.I2I.4 AF.ER62OA

    S.ROKE 7O28&E HEAR.6RA.E

    CARDIAC O8./8. .O.A2

    /ERI/HERA2RESIS.ANCE

    92OOD /RESS8RE

  • 7/26/2019 Kuliah Shock Cardiogenic

    9/42

    /RDI/ OUTPUT

    Cardiac output : stok# 'ol,+# 0 h#at at#

    Stro) 0olum #load& contactilit( ; a1t#load

    2#no,s #t,n

  • 7/26/2019 Kuliah Shock Cardiogenic

    10/42

    /RDI/ OUTPUT

    Fank3Stalin" #lationshi "twn t'0ntricularnd6diastolic prssur

  • 7/26/2019 Kuliah Shock Cardiogenic

    11/42

  • 7/26/2019 Kuliah Shock Cardiogenic

    12/42

    *+-+*

    DO?

    : CAO?

    @ CO

    7O? : CAO?6C7O?B @ CO

    CAO? : SAO? @ H9 @ 3

    C7O?: S7O?@ H9 @ 3

    SHOCK, DO? 7O?

    OXYGEN TRANSPORT

  • 7/26/2019 Kuliah Shock Cardiogenic

    13/42

    CARDIOGENIC SHOCK

    Dcrasd contractility

    Incrasd llin% prssurs, dcrasd 27 stro) wor),

    dcrasd cardiac output Incrasd systmic

    0ascular rsistanc compnsatory

  • 7/26/2019 Kuliah Shock Cardiogenic

    14/42

    PATOFISIOLOGI DARI RESPONTUBUH TERHADAP SHOCK

    Respon Neuroendokrin

    Respon Hemodinamik

    Respon e!a"o#ik

  • 7/26/2019 Kuliah Shock Cardiogenic

    15/42

    H$PO%OLEIA

    R a!rium#o&'pressure s!re!()

    re(ep!ors

    Aor!a*(aro!idsHi+)'pressure

    "arore(ep!ors

    LOSS OF TONICINHIBITION OFCENTRAL ANDS$PATHETIC

    NER%OUS S$STES

    Rena#Renin re#ease

    Pi!ui!ar, +#andACTH- ADH and GH re#eas

    Adrena# +#and .medu##a/Epinep)rine*norepinep)rin

    re#ease

    Adrena# (or!e0Cor!iso# re#ease

    Adrena# (or!e0A#dos!erone re#ease

    An+io!ensin II

    De(reased rena#per1usion

    FEARS!imu#a!ion o1 #im"i(

    area o1 "rain

    Increased2),po!)a#ami(-

    adrenomedu##ar,adreno(or!i(a# a(!i3i!,

    Neuroendo(rine Respons

  • 7/26/2019 Kuliah Shock Cardiogenic

    16/42

    RESPON HEODINAIKMekanisme untuk memperbaiki keseimbangan

    kardiovaskular

    Redis!ri"usi a#iran dara)

    Penin+ka!an 4(ardia( ou!pu!5

    emper"aiki 3o#ume in!ra3asku#ar

  • 7/26/2019 Kuliah Shock Cardiogenic

    17/42

    STIULASI NEUROENDOKRIN

    H$POTENSION

    BLOOD FLO6 PROTECTEDHear!Brain

    Adrena#*pi!ui!ar, +#and

    BLOOD FLO6 DECREASEDSkin

    us(#eSp#an()ni( (ir(u#a!ion

    RESPON HEODiNAiKREDISTRIBUSI ALIRAN DARA

  • 7/26/2019 Kuliah Shock Cardiogenic

    18/42

    CARDIAC OUTPUT 7 HR 8 S%

    S,mpa!)e!i( n9 s,s!emCa!e()o#amine

    re#ease

    In(rease ED% 3ia!enoconstriction

    Arteriolar constrictionRenal reabsorption

    In(reased(on!ra(!i#i!,

    Limi!ed !o :;< "ea!s*min"e1ore de(reased CO due !o

    de(reased dias!o#i( 1i##in+!ime

  • 7/26/2019 Kuliah Shock Cardiogenic

    19/42

    Trans(api##ar, re1i## p)ase"# Decreased capillar$ pressure caused b$ %$potension

    S$mpat%etic increase in precapillar$ arteriolar constriction

    Decrease capillar$ %$drostatic pressure promotes passage o' ''rom interstitium to intravascular space

    P#asma pro!ein res!i!u!ion p)aseIncreased plasma osmolarit$ due to mainl$ %epatic release o

    glucose( p$ruvate( amino acids( etc#

    Increased interstitial osmolarit$

    Increased interstitial volume and pressure

    Transcapillar$ movement o' albumin into intravascular spac

  • 7/26/2019 Kuliah Shock Cardiogenic

    20/42

    HAEOD$NAIC RESPONSES%eno(ons!ri(!ion

    S$mpat%etic n# s$stem )SNS*+atec%olamines )+A*Angiotensin II )ATII*

    AD

    Redu(ed 3enous(apa(i!an(e

    Ar!erio#ar (ons!ri(!ionSNS( +A( ATII( AD

    De(reased (api##ar, P

    F#uid s)i1! 1rom in!ers!i!ium in!o3as(u#ar (ompar!men!

    In(reased dis!a# !u"u#arrea"sorp!ion

    A#dos!erone- ADH

    In(reased pro0ima# !u"u#arrea"sorp!ion

    SNS- CA- ATII

    In(reased m,o(ardia#(on!ra(!i#i!,

    SNS- CA

    Res!ora!ion o1"#ood 3o#ume

    In(reased

    3en!ri(u#ar1i##in+ P

    In(reased 3en!ri(u#are=e(!ion 1ra(!ion

    S%

    CO

    BPIn(reased )ear! ra!e

    SNS- CA

    In(reased S%R due !oar!erio#ar (ons!ru(!ion

    SNS- CA- ATII- ADH

    S%R

  • 7/26/2019 Kuliah Shock Cardiogenic

    21/42

    RESPON ETABOLIK

    H,per+#ikemia

    o"i#isasi #emak

    Ka!a"o#isme*peme(a)an Pro!ein,eningkatan sintesis urea,eningkatan asam amino aromatik

    Penurunan sin!esis rea(!an 1ase aku!

    Penin+ka!an osmo#a#i!as eks!rase#

  • 7/26/2019 Kuliah Shock Cardiogenic

    22/42

    RESPON ETABOLIK

    Breakdo&n o1ske#e!a# mus(#e

    in!o a9a9

    Con3ersiono1 a9a9 !o+#u(ose

    Re#ease o12Ca!e()o#aminesCor!iso#G#u(a+onGro&!) )ormone

    Impairedperip)era#

    +#u(ose up!ake

    H$PERGL$CEIA

    G#,(o+en

    "reakdo&n

  • 7/26/2019 Kuliah Shock Cardiogenic

    23/42

    EFEK SHOCK PADA TINGKATAN SEL

    H$PO8IA

    LO6'FLO6-

    POOR PERFUSION

    ANAEROBIC

    ETABOLIS

    ACIDOSIS

    DECREASED CELLULARENERG$ EFFICIENC$

  • 7/26/2019 Kuliah Shock Cardiogenic

    24/42

    CELL EBRANE FAILURE2

    DIRECTEndoto-in+omplement

    INDIRECT.ailure to maintain normal Na/( 0/or +a&/gradientDecreased o-idative p%osp%or$lation

    OSOTICGRADIENT

    6a!er en!r,in!o (e##

    CELLULAREDEA

    IPAIREDINTRACELLULAR

    ETABOLIS

    CELL

    DEATH

    Na>en!r,in!o (e##

    EFEK SHOCK PADA TINGKATAN SEL

  • 7/26/2019 Kuliah Shock Cardiogenic

    25/42

    Kidne,

    1liguric renal 'ailureig% output renal 'ailure

    Li3erLiver 'ailure

    GI !ra(! .ailure o' intestinal barrier )sepsis( bleeding*

    Lun++apillar$ leak associated 2it% or caused b$ sepsis andin'ection

    EFEK SHOCK PADA TINGKATANORGAN

  • 7/26/2019 Kuliah Shock Cardiogenic

    26/42

    PRINSIP RESUSITASI

    emper!a)ankan 3en!i#asi

    enin+ka!kan per1usi

    Terapi pen,e"a"

  • 7/26/2019 Kuliah Shock Cardiogenic

    27/42

    AINTAIN %ENTILATIONIn(reased o0,+en

    demand

    H,per3en!i#a!ion

    Respira!or, 1ai#ureRespira!or, a(idosis- #e!)ar+,'(oma- ),po0ia

    Espe(ia##, in2

    SepsisH,po3o#emia

    Trauma

    Respira!or, 1a!i+ueDi3ersi "#ood 1#o& 1rom

    3i!a# or+an

    Or+an in=ur,

  • 7/26/2019 Kuliah Shock Cardiogenic

    28/42

    H,po3o#emia ."#ood #oss/

    De(reased CO

    De(reased o0,+en de#i3er,- in(reasedo0,+en re?uiremen!

    e!a"o#i( a(idosis- ),po0emia!a(),pnea

    TREATENT2Primar, resus(i!a!ion

    O0,+ene()ani(a# 3en!i#a!ion i1 needed

    TREATENT OF RESPIRATOR$ FAILURE

  • 7/26/2019 Kuliah Shock Cardiogenic

    29/42

    TREATENT CONCEPT OF SHOCK

    ENHANCING PERFUSION * O8$GEN DELI%ER$

    O0,+en de#i3er,*DO@7HR 8 S%8 H" 8 S H" 8 paO@

    Cardia(ou!pu!

    Ar!eria# O@(on!en!

    F#uids Trans1use Par!ia##,dependen! on

    FIO@andpu#monar,

    s!a!us

    Ino!ropes

    DO@7 CO0 CaO@

  • 7/26/2019 Kuliah Shock Cardiogenic

    30/42

    .HERA/E8.IC GOA2S IN SHOCK

    Incras O? dli0ry

    Optimi1 O? contnt of "lood

    Impro0 cardiac output and"lood prssur

    &atc' systmic O? nds wit' O? dli0ry

    R0rs+pr0nt or%an 'ypoprfusion

  • 7/26/2019 Kuliah Shock Cardiogenic

    31/42

    CARDIOGENIC SHOCK&ANAGE&EN.

    .rat arr'yt'mias

    Diastolic dysfunction mayr!uir incrasd llin%prssurs

    7asodilators if not 'ypotnsi0 Inotrop administration

  • 7/26/2019 Kuliah Shock Cardiogenic

    32/42

    CARDIOGENIC SHOCK&ANAGE&EN.

    7asoprssor a%nt ndd if'ypotnsion prsnt to raisaortic diastolic prssur

    Consultation for mc'anicalassist d0ic

    /rload and aftrload rductionto impro0 'ypo$mia if "loodprssur ad!uat

  • 7/26/2019 Kuliah Shock Cardiogenic

    33/42

    F28ID .HERA/4

    Crystalloids 2actatd Rin%r5s solution

    Normal salin

    Colloids Htastarc'

    Al"umin

    Glatins

    /ac)d rd "lood clls

    Infus to p'ysiolo%ic ndpoints

    F28ID .HERA/4

  • 7/26/2019 Kuliah Shock Cardiogenic

    34/42

    F28ID .HERA/4

    Corrct 'ypotnsion rst Dcras 'art rat

    Corrct 'ypoprfusion a"normalitis

    &onitor for dtrioration of o$y%nation

    INO.RO/IC + 7ASO/RESSOR AGEN.S

  • 7/26/2019 Kuliah Shock Cardiogenic

    35/42

    INO.RO/IC + 7ASO/RESSOR AGEN.S

    Dopamin 2ow dos

  • 7/26/2019 Kuliah Shock Cardiogenic

    36/42

    INO.RO/IC AGEN.S

    Do"utamin

    J6? %+)%+min

    Inotropic and 0aria"l c'ronotropiccts

    Dcras in systmic 0ascularrsistanc

  • 7/26/2019 Kuliah Shock Cardiogenic

    37/42

    INO.RO/IC + 7ASO/RESSORAGEN.S

    Norpinp'rin

    3J %+)%+min and titrat toct

    Inotropic and 0asoprssor

    cts /otnt 0asoprssor at 'i%'

    doss

  • 7/26/2019 Kuliah Shock Cardiogenic

    38/42

    INO.RO/IC + 7ASO/RESSOR AGEN.S

    Epinp'rin

    9ot' and actions for inotropicand 0asoprssor cts

    3 %+)%+min and titrat

    Incrass myocardial O?

    consumption

    HO &8CH F28ID .O GI7EL

  • 7/26/2019 Kuliah Shock Cardiogenic

    39/42

    HO &8CH F28ID .O GI7EL

    Som masur of intra0ascular llin% /rssur

  • 7/26/2019 Kuliah Shock Cardiogenic

    40/42

    HA. DO 4O8 NEED .O KNO HEN4O8 RES8SCI.A.E A /A.IEN. IN

    SHOCKL

    Artrial "lood prssur 8rin output Systmic acid>"as "alanc

  • 7/26/2019 Kuliah Shock Cardiogenic

    41/42

    +ardiac 1utput - S!R

    Pipe3!ascularPump 7

    eart

    %o#ume3

    Blood

    $povolemic

    S%ock

    +ardiogenic

    S%ockDistributive

    S%ock

    Inotropes

    )Dob(Dop(Adr(Amr*!asopressor ) NE(,E(Adr(Dop*

    .luids

    1bstructive

    S%ock

    Release

    tamponade(etcBlood ,ressure

  • 7/26/2019 Kuliah Shock Cardiogenic

    42/42

    SUAR$ S)o(k is an a#!ered s!a!e o1 !issue per1usion se3er

    !o indu(e deran+emen!s in norma# (e##u#ar 1un(!io

    Neuroendo(rine- )emod,nami( and me!a"o#i( ()a!o+e!)er !o res!ore per1usion

    S)o(k )as man, (auses and o1!en ma, "e dia+nossimp#e (#ini(a# indi(a!ors

    Trea!men! o1 s)o(k is primari#, 1o(used on res!oriper1usion and o0,+en de#i3er, &)i#e e#imina!in+ !)